Sign In
Buy AVTX
$18.25
-1.14 (-5.88%)
At Close: Jul 31, 2026
Avalo Reports 2023 Financial Results and Provides Business Updates
04:01pm, Friday, 29'th Mar 2024
WAYNE, Pa. and ROCKVILLE, Md., March 29, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), today announced business updates and year-end financial results for 2023.
Why Is Avalo Therapeutics (AVTX) Stock Up 326% Today?
08:04am, Thursday, 28'th Mar 2024
Avalo Therapeutics (NASDAQ: AVTX ) stock is rocketing higher on Thursday after announcing a couple of positive updates for investors in the clinical-stage biotechnology company. The first big update
Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million
04:01pm, Wednesday, 27'th Mar 2024
WAYNE, Pa. and ROCKVILLE, Md., March 27, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) today announced it has acquired a Phase 2-ready anti-IL-1β mAb, which it refers to as AVTX-00
Will Avalo Therapeutics, Inc. (AVTX) Report Negative Q4 Earnings? What You Should Know
11:02am, Wednesday, 27'th Mar 2024
Avalo Therapeutics (AVTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Buy Stocks for January 3rd
08:16am, Wednesday, 03'rd Jan 2024
GWRS, SRPT, AVTX, NTGR and PAY have been added to the Zacks Rank #1 (Strong Buy) List on January 3, 2024.
Avalo Therapeutics Announces 1-for-240 Reverse Stock Split
07:00am, Wednesday, 27'th Dec 2023
WAYNE, Pa. and ROCKVILLE, Md., Dec. 27, 2023 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) today announced a 1-for-240 reverse stock split of the Company's common stock, par value $0.001
New Strong Buy Stocks for December 14th
07:31am, Thursday, 14'th Dec 2023
MUSA, AVTX, ANIK, CARG and WES have been added to the Zacks Rank #1 (Strong Buy) List on December 14, 2023.
Avalo Encourages Stockholders to Vote FOR the Reverse Stock Split
07:00am, Thursday, 07'th Dec 2023
WAYNE, Pa. and ROCKVILLE, Md., Dec. 07, 2023 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) encourages its stockholders to participate actively in the upcoming adjourned annual meeting of
New Strong Buy Stocks for November 27th
08:16am, Monday, 27'th Nov 2023
VVI, AVTX, RYI, TM and HIBB have been added to the Zacks Rank #1 (Strong Buy) List on November 27, 2023.
New Strong Buy Stocks for November 21st
08:16am, Tuesday, 21'st Nov 2023
AQST, RBT, HARP, VVI and AVTX have been added to the Zacks Rank #1 (Strong Buy) List on November 21, 2023.
Avalo Reports Third Quarter 2023 Financial Results and Provides Business Updates
07:00am, Thursday, 09'th Nov 2023
WAYNE, Pa. and ROCKVILLE, Md., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), today announced business updates and financial results for the third quarter of 2023.
Avalo Completes Divestiture of AVTX-800 Series
07:00am, Tuesday, 31'st Oct 2023
WAYNE, Pa. and ROCKVILLE, Md., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), today announced it has completed the divestiture of its rights, title and interest in, assets
Top trending biotech stocks: ANVS, MTNB, AVTX, TPST
11:26am, Thursday, 12'th Oct 2023
Biotech stocks are some of the most volatile in the market because of the regular FDA updates and mergers and acquisitions in the industry. Some of the most notable M&A events this year were Pfizer's
Avalo Therapeutics Successfully Eliminates $35 Million Debt Paving the Way for Future Growth and Innovation
07:00am, Tuesday, 26'th Sep 2023
WAYNE, Pa. and ROCKVILLE, Md., Sept. 26, 2023 (GLOBE NEWSWIRE) -- In a major achievement, Avalo Therapeutics (Nasdaq: AVTX) proudly announces the payoff of the remainder of its $35 million debt owed t
As AVTX stock price soars, Avalo Therapeutics bankruptcy remains
02:10am, Tuesday, 26'th Sep 2023
Avalo Therapeutics (NASDAQ: AVTX) stock price has become unloved and unwanted in the past few months. It has become a penny stock as it is trading at $0.1630, down from its all-time high of $91.65.
